Hepatocyte-derived microRNAs as serum biomarkers of hepatic injury and rejection after liver transplantation

Liver Transplantation

Volumn 18, Issue 3, 2012, Pages 290-297

  Farid, Waqar R R ^a   Pan, Qiuwei ^a   Van Der Meer, Adriaan J P ^a   De Ruiter, Petra E ^a   Ramakrishnaiah, Vedashree ^a   De Jonge, Jeroen ^a   Kwekkeboom, Jaap ^a   Janssen, Harry L A ^a   Metselaar, Herold J ^a   Tilanus, Hugo W ^a   Kazemier, Geert ^a   Van Der Laan, Luc J W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; BIOLOGICAL MARKER; MICRORNA; MICRORNA 122; MICRORNA 148A; MICRORNA 194; UNCLASSIFIED DRUG;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FREEZING; GRAFT RECIPIENT; HUMAN; HUMAN TISSUE; ISCHEMIA; LIVER BIOPSY; LIVER CELL; LIVER GRAFT REJECTION; LIVER INJURY; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY; THAWING;

ACUTE DISEASE; ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; FEMALE; GRAFT REJECTION; HEPATOCYTES; HUMANS; ISCHEMIA; LIVER; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MICRORNAS; MIDDLE AGED; TRANSPLANTATION, HOMOLOGOUS;

EID: 84857622379     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22438     Document Type: Article

References (48)

1. Ambros V,. The functions of animal microRNAs. Nature 2004; 431: 350-355. (Pubitemid 39265675)
2. Mack GS,. MicroRNA gets down to business. Nat Biotechnol 2007; 25: 631-638.
3. Vasilescu C, Rossi S, Shimizu M, Tudor S, Veronese A, Ferracin M, et al. MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis. PLoS One 2009; 4: e7405.
4. Tang Y, Luo X, Cui H, Ni X, Yuan M, Guo Y, et al. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum 2009; 60: 1065-1075.
5. Hezova R, Slaby O, Faltejskova P, Mikulkova Z, Buresova I, Raja KR, et al. MicroRNA-342, microRNA-191 and microRNA-510 are differentially expressed in T regulatory cells of type 1 diabetic patients. Cell Immunol 2010; 260: 70-74.
6. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008; 18: 997-1006.
7. Chen XM, Splinter PL, O'Hara SP, LaRusso NF,. A cellular micro-RNA, let-7i, regulates toll-like receptor 4 expression and contributes to cholangiocyte immune responses against Cryptosporidium parvum infection. J Biol Chem 2007; 282: 28929-28938. (Pubitemid 47610421)
8. Ferracin M, Veronese A, Negrini M,. Micromarkers: miRNAs in cancer diagnosis and prognosis. Expert Rev Mol Diagn 2010; 10: 297-308.
9. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008; 105: 10513-10518.
10. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T,. Identification of tissue-specific microRNAs from mouse. Curr Biol 2002; 12: 735-739. (Pubitemid 34455427)
11. Krützfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, Stoffel M,. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005; 438: 685-689.
12. Castoldi M, Vujic Spasic M, Altamura S, Elmén J, Lindow M, Kiss J, et al. The liver-specific microRNA miR-122 controls systemic iron homeostasis in mice. J Clin Invest 2011; 121: 1386-1396.
13. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P,. Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA. Science 2005; 309: 1577-1581. (Pubitemid 41266486)
14. Lanford RE, Hildebrandt-Eriksen ES, Petri A, Persson R, Lindow M, Munk ME, et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 2010; 327: 198-201.
15. Wang K, Zhang S, Marzolf B, Troisch P, Brightman A, Hu Z, et al. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci U S A 2009; 106: 4402-4407.
16. Laterza OF, Lim L, Garrett-Engele PW, Vlasakova K, Muniappa N, Tanaka WK, et al. Plasma microRNAs as sensitive and specific biomarkers of tissue injury. Clin Chem 2009; 55: 1977-1983.
17. Bonauer A, Carmona G, Iwasaki M, Mione M, Koyanagi M, Fischer A, et al. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 2009; 324: 1710-1713.
18. Zhang Y, Jia Y, Zheng R, Guo Y, Wang Y, Guo H, et al. Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases. Clin Chem 2010; 56: 1830-1838.
19. Bihrer V, Friedrich-Rust M, Kronenberger B, Forestier N, Haupenthal J, Shi Y, et al. Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection. Am J Gastroenterol 2011; 106: 1663-1669.
20. Tjon AS, Sint Nicolaas J, Kwekkeboom J, de Man RA, Kazemier G, Tilanus HW, et al. Increased incidence of early de novo cancer in liver graft recipients treated with cyclosporine: an association with C2 monitoring and recipient age. Liver Transpl 2010; 16: 837-846.
21. Bäckman L, Gibbs J, Levy M, McMillan R, Holman M, Husberg B, et al. Causes of late graft loss after liver transplantation. Transplantation 1993; 55: 1078-1082. (Pubitemid 23150739)
22. Patkowski W, Nyckowski P, Zieniewicz K, Pawlak J, Michalowicz B, Kotulski M, et al. Biliary tract complications following liver transplantation. Transplant Proc 2003; 35: 2316-2317. (Pubitemid 37194402)
23. Hartono C, Muthukumar T, Suthanthiran M,. Noninvasive diagnosis of acute rejection of renal allografts. Curr Opin Organ Transplant 2010; 15: 35-41.
24. Muthukumar T, Dadhania D, Ding R, Snopkowski C, Naqvi R, Lee JB, et al. Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med 2005; 353: 2342-2351. (Pubitemid 41713746)
25. Li B, Hartono C, Ding R, Sharma VK, Ramaswamy R, Qian B, et al. Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N Engl J Med 2001; 344: 947-954. (Pubitemid 32240312)
26. Anglicheau D, Sharma VK, Ding R, Hummel A, Snopkowski C, Dadhania D, et al. MicroRNA expression profiles predictive of human renal allograft status. Proc Natl Acad Sci U S A 2009; 106: 5330-5335.
27. Nathwani RA, Pais S, Reynolds TB, Kaplowitz N,. Serum alanine aminotransferase in skeletal muscle diseases. Hepatology 2005; 41: 380-382. (Pubitemid 40165383)
28. Reuben A,. Just a second. Hepatology 2003; 38: 1316-1320.
29. Perrault J, McGill DB, Ott BJ, Taylor WF,. Liver biopsy: complications in 1000 inpatients and outpatients. Gastroenterology 1978; 74: 103-106. (Pubitemid 8248893)
30. Lindor KD, Bru C, Jorgensen RA, Rakela J, Bordas JM, Gross JB, et al. The role of ultrasonography and automatic-needle biopsy in outpatient percutaneous liver biopsy. Hepatology 1996; 23: 1079-1083. (Pubitemid 26137050)
31. Bravo AA, Sheth SG, Chopra S,. Liver biopsy. N Engl J Med 2001; 344: 495-500. (Pubitemid 32164902)
32. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 1997; 25: 658-663.
33. Chen L, Yan HX, Yang W, Hu L, Yu LX, Liu Q, et al. The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma. J Hepatol 2009; 50: 358-369.
34. Barad O, Meiri E, Avniel A, Aharonov R, Barzilai A, Bentwich I, et al. MicroRNA expression detected by oligonucleotide microarrays: system establishment and expression profiling in human tissues. Genome Res 2004; 14: 2486-2494. (Pubitemid 40012232)
35. Girard M, Jacquemin E, Munnich A, Lyonnet S, Henrion-Caude A,. miR-122, a paradigm for the role of microRNAs in the liver. J Hepatol 2008; 48: 648-656.
36. Hand NJ, Master ZR, Eauclaire SF, Weinblatt DE, Matthews RP, Friedman JR,. The microRNA-30 family is required for vertebrate hepatobiliary development. Gastroenterology 2009; 136: 1081-1090.
37. Li Y, Jiang Z, Xu L, Yao H, Guo J, Ding X,. Stability analysis of liver cancer-related microRNAs. Acta Biochim Biophys Sin (Shanghai) 2011; 43: 69-78.
38. Cortez MA, Calin GA,. MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases. Expert Opin Biol Ther 2009; 9: 703-711.
39. El-Hefnawy T, Raja S, Kelly L, Bigbee WL, Kirkwood JM, Luketich JD, Godfrey TE,. Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics. Clin Chem 2004; 50: 564-573. (Pubitemid 38297307)
40. Kosaka N, Iguchi H, Yoshioka Y, Takeshita F, Matsuki Y, Ochiya T,. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem 2010; 285: 17442-17452.
41. Zhang Y, Liu D, Chen X, Li J, Li L, Bian Z, et al. Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell 2010; 39: 133-144.
42. Farid WRR, Verhoeven RCJ, de Jonge J, de Ruiter PE, Kwekkeboom J, Metselaar HJ, et al. Levels of cholangiocyte-abundant microRNAs in liver grafts prior to transplantation are predictive for long-term graft survival [abstract]. Am J Transplant 2011; 11 (suppl 2): 210-211.
43. Castro RE, Ferreira DM, Zhang X, Borralho PM, Sarver AL, Zeng Y, et al. Identification of microRNAs during rat liver regeneration after partial hepatectomy and modulation by ursodeoxycholic acid. Am J Physiol Gastrointest Liver Physiol 2010; 299: G887-G897.
44. Chen X, Murad M, Cui YY, Yao LJ, Venugopal SK, Dawson K, Wu J,. miRNA regulation of liver growth after 50% partial hepatectomy and small size grafts in rats. Transplantation 2011; 91: 293-299.
45. Kren BT, Wong PY, Shiota A, Zhang X, Zeng Y, Steer CJ,. Polysome trafficking of transcripts and microRNAs in regenerating liver after partial hepatectomy. Am J Physiol Gastrointest Liver Physiol 2009; 297: G1181-G1192.
46. Marquez RT, Wendlandt E, Galle CS, Keck K, McCaffrey AP,. MicroRNA-21 is upregulated during the proliferative phase of liver regeneration, targets Pellino-1, and inhibits NF-κB signaling. Am J Physiol Gastrointest Liver Physiol 2010; 298: G535-G541.
47. Song G, Sharma AD, Roll GR, Ng R, Lee AY, Blelloch RH, et al. MicroRNAs control hepatocyte proliferation during liver regeneration. Hepatology 2010; 51: 1735-1743.
48. Yuan B, Dong R, Shi D, Zhou Y, Zhao Y, Miao M, Jiao B,. Down-regulation of miR-23b may contribute to activation of the TGF-β1/Smad3 signalling pathway during the termination stage of liver regeneration. FEBS Lett 2011; 585: 927-934.